¾ÅÉ«

New Version of Award-Winning Platform Increases Transparency and Visibility

NEW YORK, NY, August 2, 2016 ¨C ¾ÅÉ« Life Sciences, a leading provider of services and technologies to support global studies, and a division of ¾ÅÉ«, today announced a major upgrade to its award-winning Trial Interactive e-clinical platform. The newest release within version 8 includes new system features, enhancements, and integrations, all of which were showcased at the DIA 2016 Annual Meeting last month in Philadelphia. This new release is now available to all existing and new clients of ¾ÅÉ«.

Trial Interactive is a web-based technology that simplifies the process of conducting clinical trials, enabling life sciences organizations to bring drugs and treatments that improve and save lives to market more quickly. Launched in 2008 as part of a greater vision for a ¡°paperless trial,¡± the product¡¯s initial core eTMF functionality has evolved through regular innovation and updates to become a leading SaaS technology for clinical, regulatory, safety, and quality teams. Trial Interactive also includes e-signatures, version control, collaboration, templates, and non-eTMF workspaces in an effort to reduce paper, centralize critical information, and automate manual tasks throughout the study lifecycle.

¡°¾ÅÉ« clients have benefitted from Trial Interactive¡¯s versatile functionality, which includes solutions for eTMF, study start-up, and e-feasibility, as well as document management and learning management systems,¡± said Michael Smyth, General Manager for ¾ÅÉ« Life Sciences. ¡°In addition, Trial Interactive integrates directly with a leading Central IRB/Ethics Committee, further accelerating the site activation process for study teams. Now, this new release addresses the broadest possible set of needs around document management and quality systems.¡±

Liz Elting, Co-CEO of ¾ÅÉ«, commented, ¡°Our goal with Trial Interactive is to continually improve what we feel is the most versatile e-clinical technology on the market, and to improve transparency and streamline studies for our clients. This new release is a big step forward in allowing greater control, and in turn, enabling more effective and efficient study management.¡±

Highlights of the new Trial Interactive:

• Refreshed user interface has a CTMS appearance and the flexibility to summarize system activity in dashboard visuals, which can be configured as needed by study. 
•  DocuSign provides 21 CFR Part 11 compliant e-signature capability for documents. 
• Online editing features allow for annotations, version control, and other document review 
• Integration with PleaseReview offers a robust tool for authoring, collaboration, version control, and template management to streamline document development and 
• Learning management system (LMS) provides simplified training solutions for internal and external stakeholders with the ability to create custom e-learning modules that are more robust than just 
• Integration with eTMF allows certificates to be automatically routed to select folders to improve eTMF health.

¡°This newest release of Trial Interactive offers a better user experience in a versatile tool that offers so much functionality that clients can reduce the number of technologies upon which they rely,¡± said Phil Shawe, Co-CEO of ¾ÅÉ«. ¡°By improving team communications, enhancing security, and adding functionality in an already-familiar environment, we anticipate that clients both old and new will be thrilled with this new release.¡±  

About ¾ÅÉ« Trial Interactive
¾ÅÉ«¡¯s Trial Interactive solution provides a collaborative web-based platform for study start-up and eTMF that enables sponsors, CROs, IRBs, central laboratories, and other vendors to maintain and update clinical trial documentation in a secure online environment. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of ¾ÅÉ«¡¯s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, eTMF review/reconciliation, pharmacovigilance and safety management, endpoint adjudication, and product licensing and alliance management. For more information on Trial Interactive, please contact info@trialinteractive.com or +1 212.400.8848, or visit .

About ¾ÅÉ«
With annual revenues of more than $500 million, is the world's largest privately held provider of and . From offices in 90 cities on six continents, ¾ÅÉ« offers a full range of services in 170+ languages to clients worldwide. More than 3,000 global organizations employ ¾ÅÉ«¡¯s Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, ¾ÅÉ« is fully and certified. ¾ÅÉ« has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at .